Advertisement
Screener

F-STAR THERAPEUTICS, INC. Research and Development Expense

F-STAR THERAPEUTICS, INC. Research and Development Expense

F-STAR THERAPEUTICS, INC. reported Research and Development Expense of $9.67 million for the 3-month period ending 2022-09-30, per its 10-Q filed 2022-11-10.

Discontinued › Expense Statement › Operating Expenses

us-gaap:ResearchAndDevelopmentExpense · last filed 2022-11-10

  • F-STAR THERAPEUTICS, INC. research and development expense for the quarter ending 2022-09-30 was $9.67M, a 89.13% increase year-over-year.
  • F-STAR THERAPEUTICS, INC. research and development expense for the quarter ending 2022-06-30 was $8.72M, a 5.22% increase year-over-year.
  • F-STAR THERAPEUTICS, INC. research and development expense for the quarter ending 2022-03-31 was $8.04M, a 12.69% increase year-over-year.
  • F-STAR THERAPEUTICS, INC. research and development expense for the quarter ending 2021-12-31 was $8.21M, a 139.27% increase year-over-year.
  • F-STAR THERAPEUTICS, INC. research and development expense for fiscal 2021 was $28.75M, a 103.50% increase from fiscal 2020.
  • F-STAR THERAPEUTICS, INC. research and development expense for fiscal 2020 was $14.13M, a 54.99% decline from fiscal 2019.
  • F-STAR THERAPEUTICS, INC. research and development expense for fiscal 2019 was $31.39M, a 58.91% increase from fiscal 2018.
  • F-STAR THERAPEUTICS, INC. research and development expense for fiscal 2018 was $19.75M, a 51.06% increase from fiscal 2017.
Period endResearch and Development Expense 3 monthResearch and Development Expense 3 month as first filedResearch and Development Expense 6 monthResearch and Development Expense 6 month as first filedResearch and Development Expense 9 monthResearch and Development Expense 9 month as first filedResearch and Development Expense 12 monthResearch and Development Expense 12 month as first filed
2022-09-30$9.67M
10-Q · filed 2022-11-10
$18.39M
derived: sum of 2 quarters · filed 2022-11-10
$26.43M
10-Q · filed 2022-11-10
$34.65M
derived: sum of 4 quarters · filed 2022-11-10
2022-06-30$8.72M
10-Q · filed 2022-08-11
$16.76M
10-Q · filed 2022-08-11
$24.98M
derived: sum of 3 quarters · filed 2022-08-11
$30.09M
derived: sum of 4 quarters · filed 2022-11-10
2022-03-31$8.04M
10-Q · filed 2022-05-10
$16.25M
derived: sum of 2 quarters · filed 2022-05-10
$21.36M
derived: sum of 3 quarters · filed 2022-11-10
$29.66M
derived: sum of 4 quarters · filed 2022-11-10
2021-12-31$8.21M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
$13.33M
derived: sum of 2 quarters · filed 2022-11-10
$21.62M
derived: sum of 3 quarters · filed 2022-11-10
$28.75M
10-K · filed 2022-03-15
2021-09-30$5.11M
10-Q · filed 2022-11-10
$13.40M
derived: sum of 2 quarters · filed 2022-11-10
$20.54M
10-Q · filed 2022-11-10
$23.97M
derived: sum of 4 quarters · filed 2022-11-10
2021-06-30$8.29M
10-Q · filed 2022-08-11
$8.44M
10-Q · filed 2021-08-13
$15.42M
10-Q · filed 2022-08-11
$15.70M
10-Q · filed 2021-08-13
$18.86M
derived: sum of 3 quarters · filed 2022-08-11
$24.18M
derived: sum of 4 quarters · filed 2022-08-11
2021-03-31$7.13M
10-Q · filed 2022-05-10
$7.27M
10-Q · filed 2021-05-17
$10.56M
derived: sum of 2 quarters · filed 2022-05-10
$15.89M
derived: sum of 3 quarters · filed 2022-05-10
$17.98M
derived: sum of 4 quarters · filed 2022-05-10
2020-12-31$3.43M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-15
$8.75M
derived: sum of 2 quarters · filed 2022-03-15
$10.85M
derived: sum of 3 quarters · filed 2022-03-15
$14.13M
10-K · filed 2022-03-15
2020-09-30$5.32M
10-Q · filed 2021-11-10
$2.52M
10-Q · filed 2020-11-03
$7.41M
derived: sum of 2 quarters · filed 2021-11-10
$10.70M
10-Q · filed 2021-11-10
$11.02M
10-Q · filed 2020-11-03
$24.13M
derived: sum of 4 quarters · filed 2021-11-10
2020-06-30$2.09M
10-Q · filed 2021-08-13
$3.20M
10-Q · filed 2020-08-10
$5.49M
10-Q · filed 2021-08-13
$8.51M
10-Q · filed 2020-08-10
$18.81M
derived: sum of 3 quarters · filed 2021-08-13
$24.04M
derived: sum of 4 quarters · filed 2021-08-13
2020-03-31$3.40M
10-Q · filed 2021-05-17
$5.30M
10-Q · filed 2020-05-07
$16.72M
derived: sum of 2 quarters · filed 2021-05-17
$21.94M
derived: sum of 3 quarters · filed 2021-05-17
$29.22M
derived: sum of 4 quarters · filed 2021-05-17
2019-12-31$13.32M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30
$18.54M
derived: sum of 2 quarters · filed 2021-03-30
$25.82M
derived: sum of 3 quarters · filed 2021-03-30
$31.39M
10-K · filed 2021-03-30
$23.27M
10-K · filed 2020-02-14
2019-09-30$5.23M
10-Q · filed 2020-11-03
$12.50M
derived: sum of 2 quarters · filed 2020-11-03
$18.07M
10-Q · filed 2020-11-03
$22.63M
derived: sum of 4 quarters · filed 2020-11-03
2019-06-30$7.28M
10-Q · filed 2020-08-10
$12.84M
10-Q · filed 2020-08-10
$17.41M
derived: sum of 3 quarters · filed 2020-08-10
$23.06M
derived: sum of 4 quarters · filed 2020-08-10
2019-03-31$5.57M
10-Q · filed 2020-05-07
$10.13M
derived: sum of 2 quarters · filed 2020-05-07
$15.79M
derived: sum of 3 quarters · filed 2020-05-07
$21.34M
derived: sum of 4 quarters · filed 2020-05-07
2018-12-31$4.56M
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-14
$10.22M
derived: sum of 2 quarters · filed 2020-02-14
$15.77M
derived: sum of 3 quarters · filed 2020-02-14
$19.75M
10-K · filed 2020-02-14
2018-09-30$5.66M
10-Q · filed 2019-11-07
$11.21M
derived: sum of 2 quarters · filed 2019-11-07
$15.19M
10-Q · filed 2019-11-07
$19.11M
derived: sum of 4 quarters · filed 2019-11-07
2018-06-30$5.55M
10-Q · filed 2019-07-31
$9.53M
10-Q · filed 2019-07-31
$13.46M
derived: sum of 3 quarters · filed 2019-07-31
$16.68M
derived: sum of 4 quarters · filed 2019-07-31
2018-03-31$3.98M
10-Q · filed 2019-04-29
$7.90M
derived: sum of 2 quarters · filed 2019-04-29
$11.12M
derived: sum of 3 quarters · filed 2019-04-29
$14.53M
derived: sum of 4 quarters · filed 2019-04-29
2017-12-31$3.92M
derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-11
$7.14M
derived: sum of 2 quarters · filed 2019-03-11
$10.55M
derived: sum of 3 quarters · filed 2019-03-11
$13.07M
10-K · filed 2019-03-11
2017-09-30$3.22M
10-Q · filed 2018-10-25
$6.63M
derived: sum of 2 quarters · filed 2018-10-25
$9.15M
10-Q · filed 2018-10-25
$11.92M
derived: sum of 4 quarters · filed 2018-10-25
2017-06-30$3.40M
10-Q · filed 2018-08-02
$5.93M
10-Q · filed 2018-08-02
$8.70M
derived: sum of 3 quarters · filed 2018-08-02
$11.42M
derived: sum of 4 quarters · filed 2018-08-02
2017-03-31$2.53M
10-Q · filed 2018-04-27
$5.30M
derived: sum of 2 quarters · filed 2018-04-27
$8.02M
derived: sum of 3 quarters · filed 2018-04-27
$10.96M
derived: sum of 4 quarters · filed 2018-04-27
2016-12-31$2.77M
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-20
$5.49M
derived: sum of 2 quarters · filed 2018-02-20
$8.43M
derived: sum of 3 quarters · filed 2018-02-20
$14.02M
10-K · filed 2018-02-20
2016-09-30$2.72M
10-Q · filed 2017-10-31
$5.66M
derived: sum of 2 quarters · filed 2017-10-31
$11.25M
10-Q · filed 2017-10-31
$14.01M
derived: sum of 4 quarters · filed 2017-10-31
2016-06-30$2.94M
10-Q · filed 2017-07-31
$8.53M
10-Q · filed 2017-07-31
$11.29M
derived: sum of 3 quarters · filed 2017-07-31
$13.39M
derived: sum of 4 quarters · filed 2017-07-31
2016-03-31$5.59M
10-Q · filed 2017-04-28
$8.35M
derived: sum of 2 quarters · filed 2017-04-28
$10.45M
derived: sum of 3 quarters · filed 2017-04-28
$11.99M
derived: sum of 4 quarters · filed 2017-04-28
2015-12-31$2.76M
derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-14
$4.86M
derived: sum of 2 quarters · filed 2017-02-14
$6.41M
derived: sum of 3 quarters · filed 2017-02-14
$7.54M
10-K · filed 2017-02-14
2015-09-30$2.10M
10-Q · filed 2016-10-28
$3.65M
derived: sum of 2 quarters · filed 2016-10-28
$4.78M
10-Q · filed 2016-10-28
2015-06-30$1.54M
10-Q · filed 2016-08-01
$2.68M
10-Q · filed 2016-08-01
2015-03-31$1.13M
10-Q · filed 2016-06-15